MEGIN signs distributor agreement with Blue Star in India in January 2021
MEGIN is delighted to announce that Blue Star Ltd has been selected as our commercial distributor and support contractor in India. This exciting collaboration will allow our business to grow in this dynamic market and leveraging the local expertise and knowledge of Blue Star team really strengthens our capability to provide outstanding service to our customers.
Spectrum Healthcare’s Helen DeVos Children’s Hospital to use MEGIN TRIUX™ neo
MEGIN’s neuroimaging technology helps Spectrum Healthcare treat epilepsy and brain tumors. MEGIN is excited to expand access to MEG technology to children who need it most at the Helen DeVos Children’s Hospital and play a part in building one of the first MEG sites in the state of Michigan.
Busy times for the Customer Care Team despite COVID restrictions
MEGIN’s Customer Care Team pulled out all the stops to overcome the challenging COVID restrictions since November resulting in installations of systems in: Grand Rapids, MI; Cleveland, OH; Redwood City, CA and Seattle, WA. (Images shown above from Seattle, WA)
MEGIN’s Training team offers hybrid services
Despite COVID-19, our training team has been able to offer a hybrid service of online and on-site MEG training. MEGIN is extremely proud of our service engineers and training team members who have adapted to the ‘new normal’ to continue to deliver an excellent service for all our customers.
MEGIN extends the Product Development Team
Rasmus Zetter recently joined the MEGIN Product Development Team. He will work as a Technology Development Engineer to introduce new technologies into current and future products. He will also be supporting the growth of the MEGIN business through the identification, assessment, and development of relevant technologies.
Rasmus recently defended his PhD at Aalto University, where he worked on the development of an MEG system based on optically-pumped magnetometers (OPM) in the research group of Lauri Parkkonen. He also holds a M.Sc. in Electrical Engineering, with a strong focus on neuroimaging instrumentation. Welcome to the team, Rasmus!
MEGIN Community pilot successfully completed
The MEGIN Community pilot project was completed this week. As part of this project, MEGIN gave 6 customer sites access to the platform, which contains product documentation, online training courses and self-help articles. Among other things, MEGIN Community enables the customer to ask questions and interact online with our Customer Care Team, and complete online training courses. We are pleased to report that the platform was well received by the participants of the pilot. The customers who participated agreed that the platform worked well in a variety of environments and that it would help them with their work. Overall, these customers said they would recommend Community to their colleagues and also had excellent ideas for expanding the content to serve the broader MEG community. We are committed to continuing our investment and development of MEGIN Community to expand the content and provide a tool for communication and learning. Please contact firstname.lastname@example.org for further information and how to become a member of the MEGIN Community.
MEGIN Spotlight series guest Sven Braeutigam from the Oxford Centre for Human Brain Activity (OHBA)
A delightful guest on our latest Spotlight episode was Sven Braeutigam, Senior Researcher and MEG Physicist at the Oxford Centre for Human Brain Activity (OHBA). Sven gave us insights into the variety of ways MEG technology has been used at the Lab for major research tasks such as autism, schizophrenia, anorexia and most recently SARS-CoV2 related changes in the brain. Click below for the full interview.
MEGIN Spotlight series guest Dr James Wheless, Le Bonheur Children’s Hospital
We were excited to welcome Dr James Wheless, the Chief Neurologist and Co-director of the Neuroscience Institute at Le Bonheur Children’s Hospital in Memphis, as our spotlight guest. Dr Wheless explained how MEG Technology initially supported the Neuroscience Institute in treatment of epilepsy and brain tumor patients and subsequently expanded to neuromuscular disorders that affect children. Click below for the full interview.
MEG Community News
These news items are selected only for information purposes for our customers and MEGIN does not endorse any applications or treatments mentioned
Teen now seizure free after brain surgery using MEG Technology for pre-surgery planning at Cook Children’s in Fort Worth, Texas, USA
A fantastic case at Cook Children’s Hospital of a teen receiving life changing brain surgery and now able to live seizure free life after sixteen years of epilepsy. After reviewing the MEG results along with observations, running tests, and hundreds of pages of paperwork from the teen’s doctors over the years, Dr. M. Scott Perry, MD of Neurology and Genetic Epilepsy Clinic, was confident that he had pinpointed where the seizures were coming from. He then recommended her for epilepsy surgery. The teen was able to have her surgery and fly home two days later.
Global MEG Research Studies
Investigating the neural processing of food in Anorexia Nervosa by Oxford Centre for Human Brain Activity
An incredibly interesting MEG study conducted by Sven Braeutigam and his talented team at OHBA, a MEGIN TRIUX™ neo user, investigating the neural processing of food in anorexia nervosa (AN).
A Graph Gaussian Embedding Method for Predicting Alzheimer’s Disease Progression with MEG Brain Networks
Characterizing the subtle changes of functional brain networks associated with the pathological cascade of Alzheimer’s disease (AD) is important for early diagnosis and prediction of disease progression prior to clinical symptoms. A collaboration of CTB and MIT who used MG2G to detect the intrinsic latent dimensionality of MEG brain networks, predicting the progression of patients with mild cognitive impairment (MCI) to AD, and identifying brain regions with network alterations related to MCI. Please click below for the complete study.
Local and large-scale beta oscillatory dysfunction in males with mild traumatic brain injury